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The Frustrations of Families: Henry Lynch, Heredity,
and Cancer Control, 1962–1975
DAVID CANTOR*
When Henry T Lynch thought that he had discovered the existence of hereditary cancers
among Nebraskan families in the 1960s, his hope was that it would lead to more effective
means of cancer control. Lynch argued that the identification of such cancers offered
tremendous opportunities for improving detection and treatment. If cancer ran in families,
he claimed, the discovery of a hereditary cancer in one family member should be an alert to
the possibility of cancer in others, and so prompt careful scrutiny for any signs that might
indicate the presence of the disease in ‘‘healthy’’ individuals. Lynch hoped that by targeting
cancer families it would be possible to catch more cancers at an earlier stage than was
hitherto possible. Cancers caught early were often curable, the American Cancer Society
(ACS) claimed.1
Today Lynch is widely regarded as one of the fathers of cancer genetics, notably for his
work on hereditary cancers of the breast and colon. However, in the 1960s and 1970s such
recognition was a long way away, and few would have predicted his current eminence.
Lynch worked (then, as now) at a small, unprestigious Catholic university in Omaha,
Nebraska, far from the major centres of cancer research, and his assertions about the
hereditary nature of some cancers were not greeted with the enthusiasm he might have
wished. Many cancer experts doubted his claim to have identified hereditary cancers, and
ACS education efforts routinely stated that cancer was not a hereditary disease. Thus,
Lynch’s scheme for improving cancer detection and treatment seemed to falter almost
before it began. These problems provide an opportunity to examine the relations of heredity
to cancer in the 1960s and early 1970s, and what they tell us about cancer control in those
years.2
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1
Robert A Aronowitz, ‘Do not delay: breast cancer
and time, 1900–1970’, Milbank Quarterly, 2001, 79:
355–86.
2
On cancer control, see ibid.; Barron H Lerner, The
breast cancer wars: hope, fear, and the pursuit of a
cure in twentieth-century America, New York, Oxford
University Press, 2001; and Lester Breslow, et al.,
A history of cancer control in the United States,
with emphasis on the period 1946–1971, prepared
by the History of Cancer Control Project, UCLA
School of Public Health, pursuant to Contract
no. N01-CN-55172, Division of Cancer Control and
Rehabilitation, National Cancer Institute, Bethesda,
MD, Dept. of Health, Education, and Welfare, Public
Health Service, National Institutes of Health, National
Cancer Institute, Division of Cancer Control and
Rehabilitation, 1977. See also James T Patterson, The
dread disease: cancer and modern American culture,
Cambridge, MA, and London, Harvard University
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The fact of heredity’s marginality to cancer control in these decades will come as no
surprise to readers of this journal. It is well known that research excitement focused on viral
and environmental explanations of the disease.3 Despite vast programmes of laboratory
research on heredity in mice and other animals,4 the relatively few studies of heredity in
human populations were often greeted with scepticism by cancer experts, who found the
association between cancer and heredity unproven or insignificant.5 As importantly, I
argue, doubts about heredity also focused on the danger it posed to programmes of cancer
control. For years cancer experts had sought to wean the public off the belief that cancer
was a hereditary disease, fearing that it promoted either complacency or paralytic fear, and
so encouraged individuals to delay seeking help until after the best opportunities for
effective treatment were gone. To his critics, Lynch’s focus on hereditary cancers threatened to perpetuate these problems, and consequently to undermine the very programmes
of control that he sought to improve.
If Lynch’s advocacy of heredity reveals concerns about the impact of hereditarian
beliefs on the public, it also reveals divisions over the moral responsibility for seeking
care. Robert Aronowitz has noted that the ‘‘do not delay’’ message of control programmes
tended to make individual patients responsible for obtaining help for their cancer, while at
the same time minimizing the responsibility of physicians.6 Lynch’s approach highlights
an alternative moral universe that saw individual choice restricted by powerful psychodynamic forces, and that placed greater responsibility on the physician for ensuring that the
cancer control message got through. In his view, many physicians failed to address
patients’ emotional needs, and so tended to exacerbate the fear and stigma associated
with cancer, thus contributing to the problems of delay and what would come to be known
as compliance.7 Lynch’s efforts to shift responsibility, I argue, emerged out of a peculiar

3
Robert N Proctor, Cancer wars: how politics
shapes what we know and what we don’t know about
cancer, New York, Basic Books, 1995; Stephen P
Strickland, Politics, science and dread disease: a short
history of United States medical research policy,
Cambridge, MA, Harvard University Press, 1972.
4
Ilana Löwy and Jean-Paul Gaudilliere,
‘Disciplining cancer: mice and the practice of genetic
purity’, in Jean-Paul Gaudilliere and Ilana Löwy (eds),
The invisible industrialist: manufactures and the
production of scientific knowledge, Basingstoke,
Macmillan, 1998, pp. 209–49; Jean-Paul Gaudilliere,
‘Circulating mice and viruses: the Jackson Memorial
Laboratory, the National Cancer Institute, and the
genetics of breast cancer, 1930–1965’, in Michael
Fortun and Everett Mendelsohn (eds), The practices
of human genetics, Dordrecht, Kluwer Academic
Publishers, 1999, pp. 89–124; Jean-Paul Gaudilliere,
‘Making heredity in mice and men: the production and
uses of animal models in postwar human genetics’, in
Jean-Paul Gaudilliere and Ilana Löwy (eds), Heredity
and infection: the history of disease transmission,
London and New York, Routledge, 2001, pp. 181–202;
Jean-Paul Gaudilliere, ‘Mapping as technology: genes,
mutant mice, and biomedical research (1910–1965)’,

in Hans-Jörg Rheinberger and Jean-Paul Gaudilliere
(eds), Classical genetic research and its legacy:
the mapping cultures of twentieth-century genetics,
London and New York, Routledge, 2004, pp. 173–203;
Karen A Rader, Making mice: standardizing animals
for American biomedical research, 1900–1955,
Princeton and Oxford, Princeton University Press,
2004, esp. chs 4 and 5.
5
For one of the few exceptions to the dismissal
of hereditarian explanations of cancer, see Paolo
Palladino, ‘Between knowledge and practice: on
medical professionals, patients, and the making of the
genetics of cancer’, Soc. Stud. Sci., 2002, 32: 137–65.
See also Paolo Palladino, ‘Speculations on cancer-free
babies: surgery and genetics at St. Mark’s Hospital,
1924–1995’, in Gaudilliere and Löwy (eds), Heredity
and infection, op. cit., note 4 above, pp. 285–310; and
Paolo Palladino, Plants, patients and the historian:
(re)membering in the age of genetic engineering,
New Brunswick, NJ, Rutgers University Press, 2003.
6
Aronowitz, op. cit., note, 1 above, esp. pp. 370–5.
7
Jeremy A Greene, ‘Therapeutic infidelities:
‘noncompliance’ enters the medical literature,
1955–1975’, Soc. Hist. Med., 2004, 17: 327–43.
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intersection of cancer, medical genetics and psychology that located problems of delay and
compliance in patterns of social—especially family—interactions much more than in the
biological or psychological characteristics of an individual.8 From such a perspective,
families could be the frustration of cancer control.
Henry T Lynch
Henry T Lynch was born in Lawrence, Massachusetts, on 4 January 1928.9 He grew up
in a poor section of New York City, dropped out of school at the age of fourteen, and, in
1944, tricked his way into the US Navy, using a cousin’s identification to make himself
seem older than his sixteen years. The subterfuge was discovered, but the Navy kept him on
for the duration of the Second World War. He served in Europe, and participated in the
liberation of the Philippines, but most of the time he ploughed the Pacific as a gunner on a
merchant marine ship. Discharged from the Navy in 1946, he became a professional boxer,
working predominantly in upper New York State and the San Francisco Bay area. After this
unusual beginning for a physician, he began training in the three areas that would dominate
his professional life in the 1960s and 1970s—psychology, genetics and medicine.
Lynch took a qualifying examination to complete his high school requirements, and
went to the University of Oklahoma in Norman aiming to become a clinical psychologist.
Graduating in 1951, he moved to the University of Denver in 1952 where he took a masters
degree in clinical psychology. He then began a PhD at the University of Texas, Austin
(1953–1956), majoring in human genetics (with minors in biochemistry and psychology)
under Clarence P Oliver (1898–1991), the one-time founder and director of the Dight
Institute for Human Genetics at the University of Minnesota.10 Abandoning the PhD,
8
For the background of post-war enthusiasm for
psychology, see Nathan G Hale Jr, The rise and crisis
of psychoanalysis in the United States: Freud and the
Americans, 1917–1985, New York, Oxford University
Press, 1995; Ellen Herman, The romance of American
psychology: political culture in the age of experts,
Berkeley, University of California Press, 1995; Eva
S Moskowitz, In therapy we trust: America’s obsession
with self-fulfillment, Baltimore, Johns Hopkins
University Press, 2001; Joel Pfister and Nancy Schnog
(eds), Inventing the psychological: toward a cultural
history of emotional life in America, New Haven,
Yale University Press, 1997.
9
I am grateful to Dr Lynch for a copy of his CV.
An earlier version of his CV is available at
<http://tobaccodocuments.org/ctr/CTRMN011133-1160.
html> (accessed 18 July 2003). Details of his career are
also obtained from <http://www.whonamedit.com/
doctor.cfm/1970.html> (accessed 18 July 2003), and
from Eugene P DiMagno, ‘Lifetime Achievement
Award Henry T. Lynch, MD. International Symposium
on Inherited Diseases of the Pancreas’, in Peter Durie,
Markus M Lerch, Albert B Lowenfels, Patrick
Maisonneuve, Charles D Ulrich and David C
Whitcomb (eds), Genetic disorders of the exocrine
pancreas: an overview and update, Basel, Karger,
2002, pp. 149–53; ‘Henry Lynch’s family affair: on the

trail of inherited cancers’, Coping Magazine, May
1987, pp. 50–4; Mary McGrath, ‘Dr. Henry T. Lynch’,
Sunday World Herald [Omaha], 28 Nov. 1999, Section
R, p. 24. Details of his career are also from an interview
I conducted with Henry Lynch, 12th December 2003, in
his office at Creighton University, hereafter ‘Lynch
interview, 12th December 2003’.
10
Oliver moved to Austin in 1946, where he
established a human genetics programme at the
University of Texas and served as chair of the
department of zoology. Clarence P Oliver, ‘Human
genetics program at the University of Texas’,
Eugenical News, 1952, 37: 25–31. It is possible that
Lynch’s first contact with human or medical genetics
was during his time at Oklahoma where Lawrence
H Snyder and Paul R David provided genetic advice to
families referred to them. Snyder had been professor
in medical genetics at Ohio State University before
moving in 1947 to become Dean of the Graduate
College of the University of Oklahoma. David was
the Professor of Zoology also at the University of
Oklahoma. Daniel J Kevles, In the name of eugenics:
genetics and the uses of human heredity, Cambridge,
MA, Harvard University Press, 1995, pp. 209–10. For a
listing of North American counselling centres in the
1950s, see Lee R Dice, ‘Heredity clinics: their value for
public service and for research’, American Journal of
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Figure 1: Henry Lynch as a young man. Undated photograph, probably taken in the 1940s.
(Henry Lynch archives. Reprinted with permission of Henry Lynch.)

Lynch went on to study medicine at the University of Texas, Galveston, from where he
graduated in 1960. In succession he was an intern at St Mary’s Hospital, Evansville,
Indiana (1961); a resident in internal medicine at the University of Nebraska College
of Medicine, Omaha (1961–1964); and a USPHS fellow in clinical oncology at the Eppley
Institute for Research in Cancer and Allied Diseases, Omaha (1964–1966), during which
time he also held various lecturing positions in Lincoln, Nebraska.11 A brief appointment
followed as Assistant Professor of Biology and Assistant Internist in Medicine (Human
Genetics, and Medical Oncology) at the University of Texas, MD Anderson Hospital and

Human Genetics, 1952, 4: 1–13. A shorter version of
this article is available in Lee R Dice, ‘Counseling
centers on human heredity in North America’,
Eugenical News, 1952, 37: 32–34.
11
These positions were: Medical Genetics
Consultant and Lecturer, Department of Orthodontics,

University of Nebraska College of Dentistry, Lincoln
(1962–1965), and Lecturer in Human Genetics,
Graduate and undergraduate students, Department of
Zoology, University of Nebraska, Lincoln
(1962–1964).
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Table 1
Henry T Lynch’s appointments at Creighton University, 1967–1975.
1967–1968
1968–1970
1970–present

Assistant Professor of Medicine, Creighton University
School of Medicine
Associate Professor and Chairman, Department of Preventive
Medicine, Creighton University School of Medicine
Professor and Chairman, Department of Preventive Medicine,
Creighton University School of Medicine

Tumor Institute in Houston (1966–1967). Then in 1967, he joined the faculty of the
Creighton University School of Medicine, Omaha, Nebraska, where he remains today.12
Lynch might have trained in human genetics, but his main interest was in its clinical
applications, what he labelled ‘‘medical genetics’’, a specialty that had emerged in the late
1950s as institutionally distinct from human genetics.13 While in Galveston in the late
1950s he helped set up a clinical genetics programme in the departments of Pediatrics and
Anatomy at the University of Texas Medical Branch, along with the paediatrician, Robert
L Tips, and the anatomist, C Wallace McNutt.14 From 1959, McNutt continued the
programme in the Anatomy Department at Galveston. Tips left for the University of
Oregon Medical School in Portland, where he developed a similar programme in cooperation with a physician at the Oregon Fairview Home, George S Smith, after which both he
and Smith returned to Texas, to the Pediatrics Department at the Baylor Medical School in
Houston.15 Lynch himself moved to Nebraska, where he established a medical genetics
clinic at the University of Nebraska, College of Medicine. In 1964, Lynch took the ‘Short

12
Lynch notes that he was invited to Creighton by
the medical school dean, Richard Egan. ‘Lynch
interview, 12th December 2003’, op. cit., note 9 above.
On Lynch’s appointment, see Wayne B Leadbetter, ‘Dr.
Lynch takes over’, The Beat, SMA, The Creighton
University, Nov. 1967, 1 (2): 1, 7; ‘Two new
department heads named’, Creighton Faculty
Newsletter, Nov. 1967: 3; John M McBride, ‘Boxing,
research in cancer both part of doctor’s career’, The
Creightonian, 27 Oct. 1967: 9; ‘Noted cancer
researcher heads medical department’, The
Creightonian, 17 Nov. 1967; ‘Named head at
Creighton’, Diagnosis News, March 1968, 1 (3): 24;
‘Authority on cancer genetics to head Creighton’s
preventive medicine unit’, West Omaha and Dundee
Sun, 2 Nov. 1967.
13
Kenneth M Ludmerer, Genetics and American
society: a historical appraisal, Baltimore and London,
Johns Hopkins University Press, 1972, pp. 190–3. See
also Kevles, op. cit. note 10 above; Diane B Paul, The
politics of heredity: essays on eugenics, biomedicine,
and the nature–nurture debate, Albany, State
University of New York Press, 1998, pp. 133–56. For

British and Canadian perspectives, see, respectively,
Peter Coventry and John Pickstone, ‘From what and
why did genetics emerge as a medical specialism in the
1970s in the UK?’, Soc. Sci. Med., 1999, 49: 1227–38;
William Leeming, ‘Ideas about heredity, genetics, and
‘‘medical genetics’’ in Britain, 1900–1982’, Stud. Hist.
Phil. Biol. & Biomed., 2005, 36: 538–58; and William
Leeming, ‘The early history of medical genetics in
Canada’, Soc. Hist. Med., 2004, 17: 481–500. In
addition on human genetics, see Fortun and
Mendelsohn, op. cit., note 4 above.
14
For details of this clinic, see the note in Robert L
Tips, George S Smith, Henry T Lynch and C Wallace
McNutt, ‘The ‘‘whole family’’ concept in clinical
genetics’, Am. J. Dis. Child., 1964, 107: 67–76, p. 67.
For a history of the University of Texas Medical
Branch, see Chester R Burns, Saving lives, training
caregivers, making discoveries: a centennial history of
the University of Texas Medical Branch at Galveston,
Austin, Texas State Historical Association, 2003.
15
In 1964, Tips listed his affiliation as Department
of Pediatrics, Baylor Medical School, Houston.
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Course in Medical Genetics’ organized annually since 1959 by Victor McKusick for the
National Science Foundation at Bar Harbor in Maine.16
Lynch’s vision of medical genetics revolved around what he called the ‘‘medical genetics research team’’.17 In Nebraska, this team initially comprised Lynch himself, a social
worker, Anne Krush, some medical students, and consultants from the clinical and basic
science departments of the College of Medicine in Omaha and the College of Dentistry in
Lincoln, all supported by a network of referring physicians. Founded in 1961, the team
aimed to study the various hereditary diseases recorded in the state of Nebraska, and to
determine their geographic concentration through maps of incidences of these diseases.18
Lynch claimed that, with its predominantly rural population, Nebraska was ideally suited
for genetic investigations such as he proposed. Rural families, he noted, kept careful
records of their kindred, and often several generations of the family would live within
close proximity to each other, so facilitating researchers’ contacts with them. Lynch also
noted what he called ‘‘a deep-seated pioneering tradition and philosophy in support of
worthwhile pursuits’’19 among Nebraskans that made them particularly willing to help in
his investigations.
The cooperation of patients and their families was central to Lynch’s efforts to identify
genetic diseases. According to Lynch, patients and members of the family were first
interviewed by him for information on the major manifestations of the disease in the
patient and in other members of the family.20 They would be asked about marriage,
extramarital children and the possible presence of consanguity in ancestors. Lynch stated
that he would construct a family pedigree in collaboration with the patient, asking him or
her for information on marriage, paternities, surnames, maiden names, birth dates, pregnancy histories (with careful exploration for exposures to viral and bacterial infections,
drugs and other uterine environmental hazards) and manifestations of the disease in
relatives. Patients would be asked about the presence of other genetic diseases, and
about feuds and other intra-family conflicts to obviate future problems. Lynch stated
that he would review with the patient the objects of the investigation, questionnaires
that might be sent to other members of his or her family, and he would try to obtain
permissions forms.

16
Lynch’s CV at <http://tobaccodocuments.org/
ctr/CTRMN011133-1160.html>, op. cit., note 9 above.
On the Bar Harbor course, see Ludmerer, op. cit., note
13 above, p. 191.
17
H T Lynch, Anne Krush and Rose Faithe,
‘Medical genetics in Nebraska’, Nebr. State Med. J.,
1964, 49: 406–11. On the establishment of a genetics
clinic, see H T Lynch, ‘Heredity, cancer, and the
genetics clinic’, Texas Medicine, 1967, 63: 57–61.
18
Among the sixteen types of diseases the team
studied were Dercum’s disease, transposition of the
great vessels, osteogenesis imperfecta, cystinosis,
dwarfism, diabetes, hypothyroidism, pulmonary
emphysema, and several (unspecified) forms of cancer.
19
Lynch, Krush and Faithe, op. cit., note 17 above,
p. 411. Contrast this with the secrecy that McKusick

found a problem among the Amish. M Susan Lindee,
‘Provenance and the pedigree: Victor McKusick’s field
work with the old order Amish’, in Alan H Goodman,
Deborah Heath and M Susan Lindee (eds), Genetic
nature/culture: anthropology and science between the
two-culture divide, Berkeley, University of California
Press, 2003, pp. 41–57. A revised version of Lindee’s
article on McKusick has been published as chapter 3 of
her Moments of truth in genetic medicine, Baltimore,
Johns Hopkins University Press, 2005, pp. 58–89. On
the history of rural Nebraska families, see Deborah
Fink, Agrarian women: wives and mothers in rural
Nebraska, 1880–1940, Chapel Hill and London,
University of North Carolina Press, 1992.
20
Lynch, Krush and Faithe, op. cit., note 17 above,
esp. p. 407.
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Anne Krush, Lynch’s social worker, was crucial to his efforts to secure the cooperation
of patients. Born on 27 June 1914 in Sewickley, Pennsylvania, Krush had graduated from
Wellesley College in 1936, before enrolling in the Western Reserve University School of
Medicine in Cleveland, one of only two women that year. After completing two years of
medical school, she transferred to the Western Reserve University School of Applied
Social Sciences, from where she graduated in 1941 with a Master of Science in Social
Administration. Her first job was as a medical social worker in Pittsburgh, after which she
moved to Massachusetts General Hospital in 1946, and then to Omaha, Nebraska. In 1961
she joined Lynch’s medical genetic research team as a research social worker in medical
genetics at the College of Medicine. She accompanied Lynch to the MD Anderson Hospital
in Houston, where she held a position as a Research Associate in Medical Genetics,
returning (like Lynch) to Omaha in 1967 to become an Assistant Professor of Medicine
at Creighton University. As part of Lynch’s team, Krush would obtain information from
social agencies with which the family was involved; explore issues such as the emotional
response of family members to the ‘‘family disease’’; and investigate the needs of the
family for future agency or community welfare or rehabilitation.21
In the case of cancer, Lynch and Krush were particularly impressed at the knowledge
that these families had of the disease. Many family members, they noted, seemed extraordinarily knowledgeable about the incidence and transmission of cancer in the family.22
These individuals, they claimed, were not knowledgeable of the general principles of
human genetics, yet they were able to make statements strongly implicating the likelihood
of hereditary factors, repeatedly referred to themselves as being part of a cancer family, and
so provided important clues for physicians to identify hereditary cancers. Not only did they
provide clues as to the identification of hereditary cancers, they also provided an opportunity to explore popular attitudes and feelings towards such diseases.23 Lynch and Krush
noted, for example, that the genealogical records kept by one family set the stage for much
internal family discussion about the ‘‘family disease’’, particularly among those individuals in the direct blood line who where approaching cancer risk ages. In the course of field
visits, Lynch and his colleagues used the offices of a private family physician to stage what
they called a ‘‘family reunion’’,24 which provided the opportunity for individuals not only
to comment on the ‘‘family tree’’ (or pedigree), but also for Lynch and his colleagues to
begin to study the responses of individuals towards cancer.25
21
Ibid. Biographical information on Krush is taken
from, ‘The Anne J. Krush Fund for Education and
Research in Hereditary Colorectal Cancer Syndromes’,
<http://hopkins-gi.nts.jhu.edu/pages/latin/giving/
annekrush.cfm> (accessed 17 April 2005).
22
Anne J Krush, Henry T Lynch and Charles
Magnuson, ‘Attitudes toward cancer in a ‘‘cancer
family’’: implications for cancer detection,’ Am. J.
Med. Sci., 1965, 249: 432–8. One of the clues to the
identification of his first cancer family came from his
first CFS patient, who explained that he drank
excessively because he knew he would one day die of
cancer, like all members of his family. Henry T Lynch,
Thomas Smyrk, and Jane F Lynch, ‘Molecular genetics
and clinical-pathology features of hereditary

nonpolyposis colorectal carcinoma (Lynch syndrome):
historical journey from pedigree anecdote to molecular
genetic confirmation’, Oncology, 1998, 55: 103–8,
p. 104.
23
Krush, Lynch and Magnuson, op. cit., note 22
above.
24
Ibid., p. 433.
25
Ibid., p. 434. See also the movie, The family tree.
Cancer genetics: guide to early diagnosis, University
of Texas M D Anderson Hospital and Tumor Institute at
Houston and the Richardson Foundation, produced by
Medical Communications, Houston, University of
Texas, 1967. Copy available in National Library of
Medicine (QZ 241 VC no.2 1967).
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If family members were important to the identification of genetic diseases, they were
also a problem. Individuals had faulty memories, and limited knowledge of the real nature
of disease. They did not know the secrets of other members of the family, and the records
they provided—bibles, photographs, diaries and so on—had limited value in identifying
specific diseases. As McKusick had found earlier, all this raised questions about the
reliability of knowledge produced from such sources.26 Thus, Lynch and Krush supplemented the interviews with evidence from other sources: medical records, historical
archives, libraries, census data, and the records of genealogical societies.27 They would
also supplement patients’ records and recollections with histological observations and
autopsy material. Lynch and Krush contrasted the certainty of the results achieved by
such a combination of interview and pathological observation favourably with pedigrees
based on unconfirmed reports and rumours—a characteristic, he claimed, of earlier human
genetics studies. Their approach was, they noted, ‘‘in keeping with modern medical
genetics research as opposed to earlier studies in human genetics where emphasis was
placed upon history alone with pedigree construction resting predominantly on hearsay
evidence.’’28 Lynch also contrasted it with what he called ‘‘bizarre misconceptions based
on folklore and old wives’ tales’’29 that families might harbour and offer as causes for the
occurrence of particular lesions. In such ways, Lynch and Krush sought to distance medical
genetics both from human genetics and from popular understandings of disease and
heredity.
Family Cancers
Lynch’s interest in cancer and heredity began shortly after his arrival in Omaha. He
recounts that in 1962 or 1964 Charles Magnuson, a gastroenterologist at the Omaha
Veterans Administration Hospital, requested that he consult on a patient with a strong
family history of colorectal cancer.30 Magnuson felt that familial adenomatous polyposis
(FAP) was most likely the problem in the family, since FAP was the only known hereditary
disorder predisposing to colorectal cancer.31 However, when Lynch and Krush drew up a
detailed pedigree, they found a strong predilection for colorectal cancer, but in the absence
of multiple colonic polyps. Lynch presented his findings at a meeting of the American

26

Lindee, op. cit., note 19 above.
Lynch’s interest in collecting such information
led him to criticize the common hospital practice of
destroying old medical records, see Henry T Lynch and
Anne J Krush, ‘The life and death of medical records’,
JAMA, 7 December 1970, 214: 1890.
28
Lynch, Krush and Faithe, op. cit., note 17 above,
p. 410.
29
Henry T Lynch, ‘Skin, heredity and cancer’,
Cancer, 1969, 24: 277–88, p. 286.
30
Lynch, Smyrk, and Lynch, op. cit., note 22 above;
Alan G Thorson, Joseph A Knezetic and Henry T
Lynch, ‘A century of progress in hereditary
27

nonpolyposis colorectal cancer (Lynch Syndrome)’,
Diseases of the Colon and Rectum, 1999, 42: 1–9.
Details of the work can be found in the ‘Family register’
compiled by Lynch for members of Family N. in 1978,
Papers held by Henry Lynch at the Creighton
University (hereafter Lynch archives). The register
states that the first patient was referred in 1964, the
others state 1962.
31
On FAP, see Palladino, ‘Between knowledge and
practice’, op. cit., note 5 above. See also Palladino,
‘Speculations on cancer-free babies’ and Palladino,
Plants, patients and the historian, both op. cit., note 5
above.
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Society of Human Genetics in 1964. The story goes that his presentation reminded
Marjorie Shaw, a medical geneticist at the University of Michigan (Ann Arbor), of another
family with similar genetic and clinical manifestations. In 1966, she, Lynch, Krush,
Magnuson and Arthur L Larsen, a pathologist at the University of Nebraska Medical
Center, published their first report on the two families—family N from Nebraska, and
family M from Michigan.32 It was the beginning for Lynch of a long-standing interest in
what would come to be known as ‘‘cancer family syndrome’’ (CFS)33—now ‘‘hereditary
non-polyposis colorectal cancer’’ (HNPCC) or ‘‘Lynch’s syndrome’’.34
Lynch tells the story of the beginnings of his interest in CFS as one of happenstance. But,
if it happened by chance, it happened to someone who had already thought about hereditary
cancers and how they might be studied. In the 1950s and early 1960s, Lynch’s former
mentor in Austin, Clarence Oliver, was one of a small number of researchers that began to
explore the role of heredity in human cancers. Until then, the bulk evidence of such cancers
had come from experimental research on laboratory animals, especially mice.35 By contrast, Oliver and other geneticists turned to human populations to study the role of heredity
in a variety of cancers such as the breast, stomach, colon, and prostate, as well as the
leukaemias and lymphomas. Oliver, for example, used family studies to research the
hereditary contribution to risk of breast cancer, concluding that close relatives of breast
cancer patients had an increased risk of developing the disease, which he attributed to
shared genes.36 Thus, when Lynch identified his first case of a familial predilection
towards colorectal cancer in the absence of colonic polyps, he was building on a growing
number of family studies that explored the hereditary nature of the disease. Indeed, his
medical genetics research team was also identifying a number of other familial malignancies in Nebraska, including cancers of the breast, stomach and prostate.37 It was
probably the work of this team that prompted Magnuson to turn to Lynch for help
with his colorectal patient.

32
H T Lynch, M W Shaw, C W Magnuson, A L
Larsen, and A J Krush, ‘Hereditary factors in cancer:
study of two large midwestern kindreds’, Arch. Intern.
Med., 1966, 117: 206–12.
33
Ibid. Lynch described CFS as a pedigree
involving a high occurrence of adenocarcinomas of
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The idea that people might be hereditarily predisposed to cancer was not new. Nineteenth- and early-twentieth-century physicians routinely wrote about a predisposition
towards disease acquired through heredity, or through the insults to the body accumulated
over a lifetime, or through some combination of both.38 What was different about the
notion of heredity that Oliver, Lynch and other geneticists employed was—as Lynch
himself noted39—the use of statistics to identify the genetic nature of the predisposition.
In such studies, researchers would examine large populations affected with the disease,
analyse the ‘‘relative risks’’ for various factors such as sex or the number of family relatives
with the disease, and then draw conclusions about their roles in promoting cancer.40 The
link between heredity and cancer, therefore, tended to be expressed in terms of frequency
or probability. For example, Lynch characterized CFS as involving—among other factors—an increased frequency of adenocarcinomas, particularly adenocarcinomas of the
colon and endometrium, and an increased frequency of multiple primary malignant neoplasms. Individuals in cancer families, Lynch claimed, had a greater probability of succumbing to these cancers than the population at large, though they did not have a greater
probability of succumbing to other types of cancer. CFS was, therefore, probably a genetic
disease, he noted, and the genotype was probably specific to CFS.41
Lynch may have been persuaded that CFS was hereditary, but others were not. Critics
suggested that he had not taken adequate account of environmental or viral factors in his
studies of cancer families. Thus, in the late 1960s—as Lynch relates the story—an NIH
site-team expressed strong doubts about his claims for the genetic basis of CFS. In its view,
Lynch had not conclusively demonstrated that CFS families were the product of heredity:
they could be chance clusters of cancer, or due to common environmental exposures, or the
result of ascertainment bias. The site-team advised him to look for common environmental
factors in the rural families he studied.42 Others targeted his pathological work as
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problematic. Lynch recalls an incident at a European meeting when an unnamed43
gastrointestinal pathologist informed him that CFS families were simply FAP with
inadequate pathologic study. To Lynch’s embarrassment, the pathologist was proved
right in one case. One of the first alleged CFS families was later shown to have an
attenuated variant of FAP.44
In Lynch’s view, the attack on CFS was but one instance of a broader assault on studies
that pinpointed heredity as a significant cause of human cancers. Echoing the plaints of
many medical geneticists, he claimed that critics routinely sought to dismiss such studies
by suggesting that results were distorted by problems of data collection and analysis, as
when they pointed to issues of the adequacy of pathologic study or ascertainment bias.
They also sought to dismiss such studies by suggesting that their failure to find classical
Mendelian patterns of inheritance in all but a handful of cancers undermined claims for a
significant role for heredity. The major cancers of the breast, colon, stomach, endometrium, prostate and lung were often associated with an increase in risk to relatives of
individuals blighted by such diseases. Yet none exhibited a simple genetic inheritance
pattern, and so allowed for the possibility that other factors might be at work besides
heredity. Few critics would have suggested that heredity had no role in cancer; just that it
had no significant role.
Frustrated with his critics, Lynch was moved to label them so unsophisticated in medical
genetics as to ‘‘expect a definite [Mendelian] genetic pattern in human family histories, or
otherwise . . . discredit genetics as one factor in cancer development.’’45 (This claim of
unsophistication was made despite the fact that the NIH site team mentioned above
included what Lynch later called ‘‘distinguished’’ geneticists and epidemiologists.46)
Patterns of inheritance might be there awaiting discovery, he suggested, but the natural
history of the disease and methodological problems of human genetics got in the way of
discovery. For example, in the case of breast cancer he noted that the late stage of onset and
the lack of complete ascertainment of relatives could obscure the recognition of simple
genetic inheritance (a claim that may have confirmed his critics in their concerns that his
methods distorted his results.) Equally problematic, in Lynch’s view, was the possibility
that environmental and other extra-genetic factors might work against the discovery
of such patterns of inheritance. Quoting his former mentor, Clarence Oliver, Lynch
speculated that in the case of breast cancer the high frequency of solitary cases might
be due to the existence of two groups of causes of cancer, one hereditary, one environmental. These patterns, he suggested, might be due to an inter-relationship between genes
43
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Figure 2: Today, Henry Lynch is a leading figure in cancer genetics, his numerous papers presented
to packed conferences. This was not always the case. In the 1960s and 1970s, Lynch’s audiences
could be significantly smaller. Henry Lynch (left) and an unidentified individual at a poster session.
Undated photograph, probably late 1960s/early 1970s. (Henry Lynch archives. Reprinted with
permission of Henry Lynch.)

and an unknown environmental agent in which the gene may be present but unexpressed
unless the proper environment coexisted.47
Such arguments, however, did not persuade his detractors, and Lynch found himself
preaching in a wilderness of doubt. Lynch argued that the impact of genetics on the body
and disease was always dependent on an interplay of genetics with environmental and
social factors. The genetic constitution of an individual was, he claimed, ‘‘an instrument
played upon by a variable environmental symphony’’,48 that included viruses, tobacco,
aniline dyes, coal tar, hydrocarbons, radiation, nitrogen mustards, and other carcinogens.
He also noted that national and ethnic differences such as occupations, industrial exposures, food habits, climate, sexual customs, breast-feeding, and fecundity might be
47
Lynch and Krush, op. cit., note 39 above, p. 603.
The original comments are in Oliver, ‘Studies on
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again, in the case of CFS, the non-Mendelian character
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suggest other factors at work besides autosomal
dominant inheritance, such as cytoplasmic inheritance
or virus factors or both. Lynch, Shaw, Magnuson,
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important to the onset of cancer.49 But, disentangling the parts played by each member of
this symphony orchestra proved a difficult problem. It was quite unclear what was the
mode of inheritance, the role of heredity in promoting susceptibility or resistance to cancer,
or the relative contributions of heredity and environment.50 Lynch saw such problems as
mere obstructions to a better understanding of the role of heredity in cancer. The problem
for him was that his critics were not persuaded that heredity was a problem significant
enough to warrant such investigation; that they worried that Lynch’s methods of study
might have distorted his results; and that, perhaps, Lynch was himself predisposed to find
what he was looking for and so underestimated the significance of other explanations.
As such doubts persisted, Lynch came to believe that they had less to do with science and
more to do with the prejudice of major East-coast institutions against a small, mid-western
university that challenged the orthodoxy. He, therefore, threw himself back into his
research, accumulating more and more empirical data in the hope of changing minds,
and publishing the results in a wide range of (sometimes prestigious) journals.51 To this
end, he turned more and more to Nebraskan institutions and individuals for support.
Creighton University gave Lynch considerable freedom to continue his research.52 The
Omaha-based Eppley Institute funded some of his research when outside monies were hard
to get, as did the Nebraska ‘‘Aerie’’ of the Fraternal Order of Eagles.53 Nebraskan
physicians, Lynch noted, showed themselves enthusiastic about the project, making
medical records available, conducting laboratory and physical examinations for the
team, donating the use of their facilities and serving as liaisons between the team and
the families.54 And finally, Nebraskan families—and later families from other states—
welcomed him into their homes, and provided him with data crucial to his research. Critics
may have looked down on Nebraska, but Nebraska was to be the saving of Lynch.
Control and Delay
Lynch was interested not only in identifying hereditary cancers, but also in controlling
them. In his view, the identification of such cancers provided new opportunities for
49
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recognizing the disease early in its development when it could be most effectively treated.
The detection of a hereditary cancer in one family member should, he suggested, prompt
greater vigilance for the possibility of cancer in others, otherwise ‘‘healthy’’. Yet, if Lynch
had hoped that members of cancer families would rush to their physicians at the first sign of
what might be the disease, he was often disappointed. Many seemed to avoid seeking help,
even if they suspected cancer and knew of relatives with the disease. Indeed, it seemed to
Lynch that the presence of cancer in the family might compound the problem. Familial
cancers were often regarded as a ‘‘disgrace’’,55 and individuals delayed not least because of
what they had seen it do to others. Thus, Lynch and Krush highlighted the case of one
patient—with a huge ulcerating carcinoma involving her entire left breast—who
explained: ‘‘Though my mother and two sisters had surgery for breast cancer, they
died in a horrible way . . . I decided to ignore mine as long as possible because there
is no hope.’’56
Lynch was not the first to note the problem of delay.57 Nor was he the first to suggest
hereditarian beliefs might compound the problem. For years cancer experts had argued that
the popular belief that cancer was hereditary worked against programmes of early detection
and treatment by dissuading people from seeking help. Such a belief, they claimed,
encouraged fatalism among those who had relatives with cancer, and complacency
among those who did not. If heredity did contribute to cancer, they suggested, it contributed
such a small amount, that any mention of it might do more damage than good. Consequently, most cancer education programmes invested huge efforts in educating the public
in the belief that cancer was not a hereditary disease.58 It was, from their perspective, often
better to deny bluntly that heredity contributed to cancer, than to risk perpetuating popular
misconceptions about it by highlighting its limited role in promoting the disease.59 Such
55
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attitudes—combined with doubts about Lynch’s claim to have identified hereditary
cancers—were to prove a major problem for his efforts to promote heredity as a
means of improving cancer control. The fact that he himself found that would-be patients
delayed because of the stigma and fears generated by familial cancers did not help his case.
Lynch’s answer to this quandary focused on devising means of tackling emotional and
psychological responses to hereditary cancers (in addition, that is, to his continued efforts
to persuade his colleagues of the importance of heredity to human cancer). In his view, such
responses were often neglected. Physicians knew little about their patients, still less about
their families; education programmes were aimed at the mass rather than the individual;
and genetic counselling addressed only the facts of heredity rather than psychological and
emotional reactions to the identification of a genetic condition in the family. All this left
would-be patients and their families confused, and failed to address the complex factors
that promoted delay. It was all too easy, Lynch argued, for control measures to be undermined by the tides of fear, denial, evasion, guilt and apathy that he detected in patients and
their families during his field investigations.60 Only by a detailed personal knowledge of
patients and their families would it be possible to channel individuals to appropriate
specialist care; to ensure that they got such care in a timely manner; and that they continued
with care during what could be a long, painful and uncertain course of treatment.
Thus, Lynch envisaged a state-wide network of cancer clinics and hospitals; supported
by ancillary laboratory, registry and diagnostic facilities; linked by a referral system that
passed sick or at-risk patients to appropriate specialist help; and all sustained by public
education programmes that encouraged people to seek help.61 At the heart of this system
was to be the family physician, the gateway to the rest of the network.62 In Lynch’s view,
the family physician was the physician most likely to be aware of cancer in the family; best
placed to spot the sometimes subtle early warning signs of the disease; and, as a trusted
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family friend, the best candidate to persuade people to undergo regular screening, to direct
them to appropriate specialists if cancer was discovered, and to convince them to stay the
course of treatment when the going got tough. His vision was of a network of such
physicians across the state (and the country) monitoring (cancer) families, and feeding
those affected by the disease to specialist centres where they could get suitable care.63
Lynch argued that physicians should ‘‘assume the role of both teacher and partner’’64 to
their patients. They would correct misconceptions about the disease and heredity; encourage people to seek regular detection examinations; and combat the irrational fears that
many individuals had of the disease and heredity. He was particularly hopeful of cancer
education at the grade school or early high school level, when the student first encountered
science and biology. Teaching students the facts about cancer, he believed, could serve as a
platform from which to combat the fear associated with learning about cancer later in
adulthood, especially if the early cancer education emphasized the positive aspects of
cancer control through early diagnosis. Accordingly, Lynch’s department launched a
programme in which junior and senior medical students visited local schools to discuss
the biological aspects of cancer and its social ramifications.65
But physicians could do only so much. Building on his experience in Galveston—where
he, Tips, Smith, and McNutt had developed a model of ‘‘whole family’’ or ‘‘family
centered’’ genetic counselling66—Lynch argued the case for clinically-trained genetic
counsellors to address the problems of hereditary cancer.67 In an increasingly specialized
and fractured health care system, such a genetic counsellor would, ideally, be someone able
to mediate all the information given to patients and their families; provide a more nuanced
communication of the nature of disease and heredity; address the families’ emotional
responses to these efforts; and elicit better information on other family members who
might be at risk. Moreover, if the counsellor was also the cancer specialist, he or she could
bring together the various medical and social services that the patient and his or her family
would need to deal successfully with the problem. Thus, Lynch promoted an ‘‘integrative
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psychologic approach’’ to counselling, providing what he called total medical and
psychosocial evaluation and support to a patient and his or her family.68 Given contemporary moves in the Nebraska of the late 1960s and early 1970s to promote screening for
other genetic conditions there may have been optimism that such a scheme could have been
instituted.69
Problems
The rudiments of a system of cancer control had existed in Nebraska since the early
1920s.70 But, until Lynch arrived in the state, cancer experts had tended to see hereditarian
beliefs as a hindrance to cancer control rather than a help. Part of the problem has already
been mentioned: hereditarian beliefs, experts suggested, tended to promote delay, and
consequently Nebraskan cancer programmes, like those elsewhere, tended to educate the
public in the belief that cancer was not a hereditary disease. But, hereditarian beliefs also
raised another problem. Experts worried that they prompted eugenic concerns that cancer
control might increase the hereditary burden of cancer, and so might weaken medical and
state support for anti-cancer efforts. Thus, for example, in 1939 an editorial in the state
medical journal reassured its readers that early cancer detection and treatment would
‘‘more than offset such handicaps as heredity may impose’’.71 By the 1960s, concerns
about negative impact of eugenics on cancer control appear to have dissipated; commentators suggested that eugenics was no longer a popular concern.72 But for Lynch a new set
of problems had emerged.
As relations between eugenics and genetics were reconfigured after the Second World
War, attention began to shift towards what Sheldon C Reed, Director of the Dight Institute
for Human Genetics, called ‘‘non-directive genetic counseling’’. In non-directive counselling, the genetic counsellor was little more than a purveyor of technical—‘‘value-free’’—
information on heredity. Reed suggested that the decision of what to do with this information be left to the family rather than to state or other agencies.73 Lynch was dismayed by
such suggestions. Describing Reed’s approach as ‘‘cold, mathematical, and stereotyped’’,74 he claimed it neither fully characterized the manifold needs of a family with
a genetic condition, nor provided insight into how to counsel such families effectively.
68
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Moreover, Lynch noted, the problems of cancer were very different to those of many other
genetic diseases. The principle concern in the case of cancer was not the question of
reproductive choice: the real problem was to persuade family members at risk to seek help,
and to seek it early. Yet all too often, he argued, individuals seemed to work against their
own best interests, risking their own lives by delaying seeking medical attention. In such
circumstances, it was insufficient to limit genetic counselling to the transmission of
technical information on heredity. The physician had to do more.
For such reasons, Lynch abandoned many of the tenets of non-directive counselling. In
his view, the lay public was vulnerable to powerful, even overwhelming (psychodynamic)
forces that limited their ability to make rational choices. It followed that physicians were
compelled to take greater responsibility for ensuring that they sought help early, and stayed
the course of treatment.75 It was a medical responsibility to ensure that the cancer control
message got through. This is not to say that Lynch argued that patients had no responsibility: indeed, he complained that education programmes were ‘‘noticeably weak in
emphasizing clearly that it is the patient who must undertake responsibility for his
own physical welfare’’.76 Nevertheless, he generally subordinated such arguments to a
view of patients and the public as subject to often irresistible forces that limited their
capacity to take such responsibility. Such limitations necessitated the active intervention of
a physician or counsellor to address the issues that encouraged delay.77
Yet almost from the start his scheme encountered difficulties. In the first place, his
efforts to address the problem of patients’ responses to the diagnosis of a hereditary
condition did little to quash medical fears that hereditary conditions might encourage
delay and prompt fear. The point was brought home to Lynch in 1977 when critics attacked
his call for a national registry system of cancer families to identify patients at risk of the
disease, and to help in the estimation of risk for particular target organs. Richard Gatti
(Director of the Division of Pediatric Oncology and Immunology at the Cedars-Sinai
Medical Center, Los Angeles) argued that such a diagnosis could leave patients quite
fearful of the disease. The fact that some in a cancer family who underwent screening did
not have cancer was hardly reassuring, since it only opened up the possibility that they
might get it in the future. Gatti proposed that further family studies be abandoned until a
genetic test was available that could give more certain prognoses. Lynch did himself no
favours by responding to Gatti that his experience in Nebraska could act as a model for
work elsewhere. As the Harvard paediatrician and human geneticist, Park S Gerald, put it:
‘‘what is acceptable in Nebraska may not be acceptable in other parts of the country’’.78
Even in Nebraska things did not go as smoothly as Lynch might have wished. Responses
to a cancer screening van that he organized in the late 1960s and early 1970s indicate the
nature of the problem. ‘‘We went around the country, Michigan, all over the place,’’ Lynch
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recalls, ‘‘screening people for cancer. We did pelvic, breast, mouth exams for free. We
gave advice to keep healthy, and it was all run by volunteers, by the community.’’79
Suddenly, however, the state funds for the project dried up. According to Lynch, a
group of Nebraskan physicians persuaded a state representative to kill the project. ‘‘It
was just greed on the part of these doctors because we were providing a free service and
they were getting paid for it before,’’ Lynch remembers. ‘‘I had just finished doing an exam
on this woman and she thanks me and says, ‘Thank you, doctor. You know, my doctor says
you are a communist, but you don’t look like a communist!’ ’’80
More generally, Lynch also came to have doubts about the ability of family physicians to
tackle the disease. Despite his hopes that the family physician would channel patients to
appropriate care, he complained that they were often ignorant of the disease, overly
pessimistic about the possibility of successful treatment, and unwilling to send patients
to trained genetic counsellors—so dissuading many would-be patients from seeking or
continuing care. How rarely, he felt, they seemed to see the problems of delay and noncompliance as problems requiring active medical intervention—and perhaps in part for
practical reasons as much as ignorance. With family physicians increasingly thin on the
ground in the 1960s and 1970s,81 Lynch and his colleagues complained that low physicianto-patient ratios did not allow sufficient time for the average family physician to practise
adequate preventive medicine—including early detection.82 In their view, patients were
increasingly being left in the dubious hands of the specialist. The fear was that specialists
often knew too little about the patient and his or her circumstances; that patients were
unable to form close personal relations with them; and that they—the patients—consequently became confused and unable to appreciate fully what was being done for them,
sometimes with dire psychological and therapeutic consequences.
To add to these difficulties, Lynch complained that there remained a disturbing ignorance of the psychology of hereditary disease among many physicians, who (inadvertently,
perhaps) encouraged fear and despair in their patients by seeking to identify those responsible for the hereditary condition. ‘‘This writer and his medical genetic colleagues’’, Lynch
wrote in 1967, ‘‘have all too frequently observed the scars and despair of patients who have
consulted and been advised by untrained individuals so that they might ‘clear up this family
problem and find out who really is to blame for the hereditary factor’.’’83 Such basic errors
of counselling were compounded, he felt, by the Reedian perception of genetic counselling
as education in the facts of genetic transmission. Such facts, Lynch argued, might be
important to the physician or counsellor, yet they were usually of relatively minor importance to the patient. Patients, he claimed, were more concerned with the emotional
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ramifications and physical consequences of a particular disorder than with formal genetic
interpretation.84
Families
It should be clear by now that the family was central to Lynch’s vision of cancer control,
and in two distinct ways. First, Lynch’s approach to cancer control involved an
understanding of the family as a hereditary or genetic entity in which certain cancers
or pre-cancerous conditions (or predispositions towards such cancers or pre-cancerous
conditions) passed from one generation to another, the actual occurrence of cancer being
the product of specific (albeit unknown) conjunctions of environmental and genetic
factors, and predicted by means of statistical probabilities derived from family studies.
From such a perspective, Lynch argued that the identification of a hereditary cancer in one
member of a family should, ideally, be followed both by attempts to persuade that individual to seek early treatment, and by the surveillance of healthy members of his or her
family so as to increase opportunities for spotting the disease at a stage in its development
most amenable to treatment.
Second, Lynch’s approach to cancer control involved an understanding of the family as a
psychosocial entity, easily disturbed by the disease, the diagnosis, or the interventions
against it. In Lynch’s view, the diagnosis of a hereditary cancer often generated complex
and sometimes conflicting responses that had to be understood in the context of the beliefs,
attitudes and patterns of emotional and mental interaction specific to individual families.
People delayed seeking medical attention, abandoned promising therapies, turned to
‘‘quacks’’, and risked economic ruin or a wrecked marriage rather than seek assistance.
They also developed strange and disturbing behaviours, such as that of the man who forced
his children to kiss him full on his tumorous lip:85 behaviours that deeply upset other family
members and so exacerbated psychological and social problems related to the disease.
All these self-destructive problems could be explained, at least in part, by reference to
the family circumstance. ‘‘Genetic problems are family problems,’’ Lynch wrote, ‘‘and are
often steeped with anxiety, guilt, fear, hostility, apprehension, ambivalence and misconceptions.’’86
The family was thus a double threat to its individual members, and hence to efforts to
promote cancer control. In Lynch’s view, it was not only a carrier of hereditary disease. It
was also the carrier of beliefs, attitudes and patterns of emotional and mental interaction
that shaped—consciously or unconsciously—individual responses to the disease. Deborah
Weinstein has shown that post-war family therapists increasingly saw mental illness as
rooted in patterns of family interactions rather than the biological or psychological
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characteristics of the individual.87 Lynch saw similar roots to the many psychological and
social problems that followed the diagnosis of hereditary cancer. In his view, it followed
that it was impossible to treat the hereditary disease without addressing the family
situation.
The problem for Lynch was that cancer control programmes rarely tackled such situations. They failed to view the family as a carrier of hereditary cancers, and so failed to
target family members at risk of the disease. They also failed to view the family as a
psychosocial entity, and so failed to target familial difficulties that promoted delay, noncompliance, or disruptive behaviours. In consequence, Lynch argued these programmes
contributed to what he called physician delay—the failure of physicians to recognize the
seriousness of the problem—as important an issue as patient delay, he claimed.88 In
Lynch’s view, control programmes needed to educate physicians about their own contributions to delay and other problems, and, indeed, to begin to take a much more interventionist approach to cancer control. As noted earlier, he argued that it was not sufficient
to place responsibility solely on the patient to seek medical assistance: people were easily
overwhelmed by the cancer or their family’s response to it. Physicians had a responsibility
to help them overcome mental and emotional barriers to care. They also had a responsibility to help them overcome the social, racial, ethnic, occupational and socio-economic
factors that promoted delay and non-compliance.89 Such responsibilities should, in
Lynch’s view, be part of any programme of cancer control.
In his efforts to promote such medical responsibilities, Lynch turned for inspiration to an
imagined older world of medicine, untainted by the increasing tendency he detected of
physicians to limit their own responsibilities and so abandon patients to their own
resources.90 His image of the family physician as friend and confidant to the family
harkened back to a mythic golden age of family practice now sadly almost gone. In
this imagined era, physicians, patients and families were bound together in complex,
long-term, evolving sets of relationships that made it quite impossible for physicians to
treat only the disease. Physicians brought their patients into the world, treated their childhood ailments, and saw them develop through adolescence, and into adulthood and old age.
They treated their parents, siblings, spouses and children. They were physicians to the
family as much as the individual patient, important figures in the local community, wellplaced to address the complex familial and social issues that illness could create. These
were the foundations upon which Lynch hoped to build a new programme of cancer
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control, reinforced by the newer insights of medical genetics, ‘‘whole family therapy’’ and
‘‘integrative psychologic approaches’’ to counselling. Control, in Lynch’s imagination,
involved a return to an older set of community values, in which family physicians took
greater responsibility for their patients’ welfare, watched them for signs of ill-health, and
intervened as only a trusted friend could when things seemed awry. Here was a vision of
‘‘surveillance medicine’’91 built on the social relations, medical practices, and ethics of an
imagined earlier age.
The family physician was thus the symbolic moral core of the cancer control system
that Lynch hoped to develop; a figure who blended the values of an older world of
medicine, with those of modern science. Lynch would have been the first to admit that
in practice physicians often did not meet such lofty values. Rather, the figure of the
family physician served to help construct a model of care and responsibility to which
cancer control programmes (and physicians within them) could aspire. In such
programmes, the family physician was, as we have already noted, to be a gatekeeper
to the cancer control system. But, he or she was also to be its ethical heart, someone
who not only referred patients to others within the system, but whose values and
approach permeated practice across the system. Cancer specialists, medical geneticists,
and genetic counsellors all had to adopt something of the approach of the family physician.
They had to know their patients and their families in all their complexity, and to take more
of the responsibility for helping them seek medical assistance, and stay the course of
treatment.
Indeed, at one point Lynch argued that because of an acute shortage of professionally
trained genetic counsellors, family physicians should assume much of the responsibility for
counselling.92 In his view, the practice of genetic counselling had many parallels with the
work of the family physician. It involved the traditional physician–patient relationship of
‘‘intimacy and confidence’’.93 Ideally, it sought to address the mental and emotional sides
of illness, as much as it addressed the biological side. It was less a science than an art. It
involved the acquisition of a broad, intimate knowledge of the patient and his or her
circumstances; an incommunicable knowledge, something ‘‘one could not possibly
hope to describe . . . in words’’.94 In genetic counselling, as in family medicine, nothing
substituted for the ineffable experience of working face-to-face with patients.95 It will
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be recalled that Lynch also suggested that the cancer specialist should assume
responsibility for counselling. But in Lynch’s vision of cancer control, this was a specialist
who shared many of the values of the family physician. Distinguished by his or
her greater knowledge of the disease and its management, this imagined specialist
(like the family physician) sought to integrate the medical, social and psychological
care of the patient and his or her family. How different this was to the current world
of cancer control, where physicians rarely knew their patients well, let alone their families,
and so failed to understand or address their emotional and mental responses to hereditary
cancers.
Yet it was an uphill struggle to promote this approach to cancer control. The
methods Lynch proposed to identify familial pathologies were undermined by the
problems of family medicine; by the enthusiasm for ‘‘non-directive’’ counselling; by
doubts about the significance of heredity to human cancers; by the contemporary
enthusiasm for viral and environmental explanations for cancer; and, perhaps, by a
reluctance on the part of many physicians to take the level of responsibility that Lynch
advocated for ensuring that their patients did not delay. Nor were Lynch’s proposals helped
by his own location in a minor educational institution, in (to the eyes of the cancer
establishment) a remote part of the country. In the 1960s and 1970s, Lynch was simply
unable to persuade most physicians and geneticists that he had identified a significant
hereditary component to human cancer, or that this might provide the basis of a new
approach to cancer control.
Lynch’s marginal position would not begin to change until the identification of the
first cancer genes in the 1990s, when his collection of family histories would become
important to molecular work on the genetics of some cancers.96 After years in the wilderness, Lynch was to see widespread acceptance of the genetic nature of a number of ‘‘his’’
cancers, albeit a genetic nature quite different to that which he had originally imagined.97
This is not to say that the new geneticists wholly embraced Lynch. It is true that he was
eventually honoured with having a number of familial, cancerous syndromes named after
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him. But suspicions remained that he had bargained his way into the molecular genetic
revolution with a resource—extensive family records—that molecular geneticists needed
for their studies, but that he did not have the technical skill or scientific credentials
necessary to take such research forward. Some critics also continued—and still continue—to regard his early work on heredity as dubious science. The irony of Lynch is
that while he came to be honoured as the one of the ‘‘fathers’’ of cancer genetics, his
‘‘children’’ sometimes quietly questioned his paternity.99
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